This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Squamous Cell Carcinoma of Nasopharynx, Squamous Cell Carcinoma of Oropharynx or Squamous Cell Carcinoma of Hypopharynx
and you are
between 18 and 75
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Oral mucositis remains a limiting factor in in head and neck squamous cell carcinomas patients treated with chemoradiation leading to pain, dysphagia, and weight loss. Low-level laser therapy emerges as a promising, preventive therapy of chemoradiation-induced OM. This study was designed to assess the efficacy of Low Level Laser Therapy (LLLT) in reducing the incidence and/or severity of oral mucositis.

Provided treatments

  • Device: Low Level Laser Therapy- (DMC, São Paulo, Brazil)
  • Device: Placebo (DMC, São Paulo, Brazil)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01439724. The sponsor of the trial is Instituto Nacional de Cancer, Brazil and it is looking for 94 volunteers for the current phase.
Official trial title:
Phase III Trial of Low-level Laser Therapy to Prevent Induced Oral Mucositis in Head and Neck Cancer Patients Submitted to Concurrent Chemoradiation